EndoGastric Solutions announced that patient enrollment has been completed for its Transoral Incisionless Fundoplication (TIF) versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD symptoms (TEMPO) trial. The ...
Tags: EndoGastric, patient enrollment, TIF, TIF procedure trial, TEMPO trial
EndoGastric Solutions has started TIF versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD Symptoms (TEMPO) trial. The controlled, multi-center, open-label, prospective, randomized study, which will enroll 51 patients, ...
Tags: EndoGastric Solutions, TEMPO trial, study, TIF